GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » EBITDA Margin %

Genetron Holdings (Genetron Holdings) EBITDA Margin % : -123.11% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Genetron Holdings's EBITDA for the three months ended in Jun. 2022 was $-25.33 Mil. Genetron Holdings's Revenue for the three months ended in Jun. 2022 was $20.57 Mil. Therefore, Genetron Holdings's EBITDA margin for the quarter that ended in Jun. 2022 was -123.11%.


Genetron Holdings EBITDA Margin % Historical Data

The historical data trend for Genetron Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings EBITDA Margin % Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial -93.97 -192.95 -709.21 -81.64 -95.55

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.52 -112.37 -157.71 -123.11 -

Competitive Comparison of Genetron Holdings's EBITDA Margin %

For the Diagnostics & Research subindustry, Genetron Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetron Holdings's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's EBITDA Margin % falls into.



Genetron Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Genetron Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-89.178/93.335
=-95.55 %

Genetron Holdings's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-25.328/20.574
=-123.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings  (NAS:GTH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Genetron Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.